Atlas Trials

Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults

Clinical trial NCT01250795 · COMPLETED

Trial details

NCT number
NCT01250795
Sponsor
Fraunhofer, Center for Molecular Biotechnology
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2010-11-01
Primary completion
2011-07-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.